These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33603124)

  • 21. Preoperative Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of 1-Year Graft Loss and Mortality After Orthotopic Liver Transplantation.
    Nylec M; Derbisz K; Chrząszcz P; Wrońska W; Król R; Wystrychowski W
    Transplant Proc; 2020 Oct; 52(8):2472-2476. PubMed ID: 32536439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
    Chae MS; Moon KU; Jung JY; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Liver Transpl; 2018 May; 24(5):623-633. PubMed ID: 29365358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume.
    Hong G; Yi NJ; Suh SW; Yoo T; Kim H; Park MS; Choi Y; Lee K; Lee KW; Park MH; Suh KS
    J Korean Med Sci; 2014 May; 29(5):640-7. PubMed ID: 24851018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The travails of setting up a living donor liver transplant program: Experience from Pakistan and lessons learned.
    Dar FS; Bhatti AB; Dogar AW; Zia H; Amin S; Rana A; Nazer R; Khan NA; Khan EU; Rajput MZ; Salih M; Shah NH
    Liver Transpl; 2015 Jul; 21(7):982-90. PubMed ID: 25891412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Liver Graft Regeneration Between ABO-Compatible and ABO-Incompatible Living Donor Liver Transplantation: A Propensity Score Matching Analysis.
    Chae MS; Lee N; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Ann Transplant; 2018 Jul; 23():507-519. PubMed ID: 30050031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of right-lobe and left-lobe living-donor liver transplantations using small-for-size grafts.
    She WH; Chok KS; Fung JY; Chan AC; Lo CM
    World J Gastroenterol; 2017 Jun; 23(23):4270-4277. PubMed ID: 28694667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil Lymphocyte Ratio can Preempt Development of Sepsis After Adult Living Donor Liver Transplantation.
    Sarin S; Pamecha V; Sinha PK; Patil N; Mahapatra N
    J Clin Exp Hepatol; 2022; 12(4):1142-1149. PubMed ID: 35814504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated High-Sensitivity Troponin I During Living Donor Liver Transplantation Is Associated With Postoperative Adverse Outcomes.
    Park J; Lee SH; Han S; Kim KY; Kim GE; Park M; Lee SK; Choi GS; Ahn S; Ahn HS; Kim GS
    Transplantation; 2018 May; 102(5):e236-e244. PubMed ID: 29298237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft selection strategy in adult-to-adult living donor liver transplantation: When both hemiliver grafts meet volumetric criteria.
    Kurihara T; Yoshizumi T; Yoshida Y; Ikegami T; Itoh S; Harimoto N; Ninomiya M; Uchiyama H; Okabe H; Kimura K; Kawanaka H; Shirabe K; Maehara Y
    Liver Transpl; 2016 Jul; 22(7):914-22. PubMed ID: 26953726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living donor liver transplantation in patients weighing ≥100 kg: Low graft weight and obesity do not impact outcomes.
    Agarwal S; Goyal N; Nayeem M; Pareek S; Gupta S
    Liver Transpl; 2017 Jan; 23(1):35-42. PubMed ID: 27731927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of donor factors to post-reperfusion severe hyperglycemia in patients undergoing living donor liver transplantation.
    Chung HS; Kim ES; Rho MC; Park CS
    Ann Transplant; 2015 Jun; 20():303-11. PubMed ID: 26037827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of Salvaged Blood Red Blood Cell Transfusion During Living Donor Liver Transplantation.
    Kim D; Heo G; Kim J; Choi GS; Joh JW; Ko JS; Gwak MS; Kim GS
    World J Surg; 2023 Jun; 47(6):1540-1546. PubMed ID: 36723663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Living Donor Liver Transplantation in Patients 70 Years or Older.
    Oezcelik A; Dayangac M; Guler N; Yaprak O; Erdogan Y; Akyildiz M; Sevdik Z; Yuzer Y; Tokat Y
    Transplantation; 2015 Jul; 99(7):1436-40. PubMed ID: 25606791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality.
    Pan ZY; Fan YC; Wang XQ; Chen LK; Zou QQ; Zhou T; Qiu BJ; Lu YF; Shen CH; Yu WF; Luo Y; Su DS
    World J Gastroenterol; 2020 Mar; 26(12):1352-1364. PubMed ID: 32256022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.